Identification of candidate hub genes for COVID-19-induced idiopathic pulmonary fibrosis by bioinformatic analysis
New Discovery · 2024
DOI: 10.61958/ndcg7201 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Discovery, 2024. Verfasst von Li Ding. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease characterized by progressive scarring leading to alveolar stiffness, and reduced lung capacity, which might be induced by Coronavirus Disease 2019 (COVID-19). This study aims to explore the molecular mechanism of COVID-19-induced IPF and find the immune changes in the process of IPF.
Methods
The data from the GEO database were processed by using the R algorithm package to explore the correlation between COVID-19 and IPF. Differential analysis, Venn analysis, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, immune infiltration analysis, transcriptional analysis, and protein-protein analysis were performed to find the candidate hub genes, related pathways, and immune cell changes in IPF.
Results
69 differentially expressed genes (DGEs) were identified by differential analysis, including 27 up-regulated genes and 42 down-regulated genes. 15 hub genes were identified, which are CEA Cell Adhesion Molecule 8 (CEACAM8), Cathelicidin Antimicrobial Peptide (CAMP), Ribosomal Protein L9 (RPL9), Lactotransferrin (LTF), CD177 Molecule (CD177), Annexin A3 (ANXA3), CD3 Delta Subunit Of T-Cell Receptor Complex (CD3D), Granulin Precursor (GRN), Granzyme A (GZMA), Granzyme K (GZMK), Interleukin 1 Receptor Type 2 (IL1R2), Lipocalin 2 (LCN2), Matrix Metallopeptidase 9 (MMP9), Neural EGFL Like 2 (NELL2) and Ribosomal Protein L4 (RPL4), among which ANXA3, IL1R2, MMP9, LCN2, NELL2 might be the most significant candidate genes for COVID-19-induced IPF. The transcriptional factors of hub genes were found to be related to Sp1 Transcription Factor (SP1), Signal Transducer And Activator Of Transcription 1 (STAT1), RELA Proto-Oncogene, NF-KB Subunit (RELA), and Nuclear Factor Kappa B Subunit 1 (NFKB1). Immune cell analysis revealed that Plasma cells, Macrophages MO, Dendritic cells activated, Mast cells resting, and Eosinophils were significantly elevated in the IPF compared with healthy subjects.
Conclusions
The findings shed light on the risk factors of COVID-19 in the development of IPF, and immune changes in COVID-19 and IPF. The shared DEGs might be prognostic in the treatment of IPF.
Zitieren
APA
Ding, L. (2024). Identification of candidate hub genes for COVID-19-induced idiopathic pulmonary fibrosis by bioinformatic analysis. New Discovery. https://doi.org/10.61958/ndcg7201
Vancouver
Ding L. Identification of candidate hub genes for COVID-19-induced idiopathic pulmonary fibrosis by bioinformatic analysis. New Discovery. 2024. doi:10.61958/ndcg7201
BibTeX
@article{Ding2024,
author = {Ding, Li},
title = {Identification of candidate hub genes for COVID-19-induced idiopathic pulmonary fibrosis by bioinformatic analysis},
journal = {New Discovery},
year = {2024},
doi = {10.61958/ndcg7201}
}
EUVIMED